Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
Interview Michel Finance, Director, Theradiag
00:00:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Interview Michel Finance, Director, Theradiag
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
The trend of big pharma brainpower moving to smaller firms to enable them to spend more time on innovation| Jeremy M. Levin, D.Phil, MB Bchir, CEO OF OVID THERAPEUTICS
00:10:00
2021 Outlook: Value, Growth, and Economic Trends with Doug Foreman at Nasdaq
00:10:00
How to Negotiate & Get What You Want|Kerry Miller,Co-Founder & Managing Partner,Overton Venture Capital
00:10:00
"Transforming Corporate Culture and Leadership: Insights from Dimensional Fund Advisors Co-CEO Dave Butler on Storytelling, Hiring Practices, and Empowering Junior Talent"
00:10:00
Understanding the Importance of Life Insurance: Insights from Phil Francois, CFP® | PHILIP FRANCOIS - CERTIFIED FINANCIAL PLANNER, Owner & Financial Planner of Foundation Wealth Planning
00:10:00
Charles Funk of Heliostar Metals Discusses High-Grade Gold Exploration at One-to-One New York Conference
00:10:00
In a conversation with Andy Headley of Veritas Asset Management, the potential of UK equities in the pharmaceutical sector is explored.
00:10:00
Sky Metals CEO Oliver Davies Discusses Talberg Project Expansion Plans
00:00:00
Per Persson, CEO of Acarix
00:10:00
Biocept's Liquid Biopsy Innovations: CEO Mike Nall Discusses 2019 Achievements and 2020 Outlook
00:10:00
SPCG's Multifaceted Solar Energy and Infrastructure Ventures under President | Ms. Wandee Kulcharnyakong Chulcharoen, CEO , Spcg PCL .
00:10:00
Viktor Garmiani Discusses Candles Scandinavia’s Q1 Performance and Future Outlook | Viktor Garmiani, CEO , Candles Scandinavia AB.